NZ too late to cannabis party to grow its own, says importer
Medical cannabis importer Nubu is in the middle of a $2.5m capital raise.
Andrew Bevin
Thu, 27 May 2021
New Zealand missed the boat on medical cannabis and is too late to the game to gain a serious foothold in the commodity space, according to Nubu Pharmaceuticals.
The medical cannabis company is in the midst of a $2.5 million series A funding round for 12.5% of the company at a pre-money
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
NZ Aviation News
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Aviation News - Monthly
NZ$14.95 / monthly
Already have an account? Login
Andrew Bevin
Thu, 27 May 2021
Contact the Writer: andrew@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
NZ too late to cannabis party to grow its own, says importer
Business,
87557